A bill to amend title XVIII of the Social Security Act to ensure more appropriate payment amounts for drugs and biologicals under part B of the Medicare Program by excluding customary prompt pay discounts extended to wholesalers from the manufacturer's average sales price.
About This Bill
Committee
Latest Action · June 9, 2009
Read twice and referred to the Committee on Finance. (text of measure as introduced: CR S6384)